DNTH

Analysts Viewpoint

A company insider recently sold 20,000 shares of Dianthus Therapeutics Inc [DNTH]. Should You Sale?

Daniel Torres

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or ...

Insiders Updates

DNTH short interest jump by 8.29%, reflecting negative sentiment

Roman Campbell

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or ...

Insiders Updates

DNTH shares expected to outperform in the next 12 months

Anna Perez

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Dianthus Therapeutics ...

Stock Earnings

Short interest on DNTH sees a significant decrease on 2025-10-31

Anna Perez

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its ...

Knox Daily
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.